Clin2
NCT07534865Likely a fitRecruiting

Heat and Hydrogen Peroxide Patch for Common Warts

Warts

Treatments studied

Part of Infections, Skin clinical trials.

This study tests a new patch that combines gentle heat with hydrogen peroxide to treat common warts on hands, feet, or fingers. The patch is applied directly to the wart and may help your body clear the infection.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
210 people
Ages
6 years to 65 years
Study type
Interventional

Who can take part

  • You are between 6 and 65 years old
  • You have at least one common wart that is 3mm or larger (about the size of a small pea or bigger)
  • Your wart is on your hand, foot, or finger
  • You have not had any other wart treatments in the past 2–4 months (depending on the treatment type)
  • You do not have diabetes, poor skin healing, or serious heart, lung, liver, or kidney disease
  • If you are a child, your parent or guardian agrees and signs the consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06812065Recruiting
Heat and hydrogen peroxide for skin warts

This trial tests whether applying heat combined with a common disinfectant (hydrogen peroxide) can safely and effectively remove viral skin warts. It may be an option if you have common, plantar, or genital warts and are between 16 and 65 years old.

Shenyang, Liaoning
NCT06827938Recruiting
Heat therapy study for warts in special groups

This study tests whether heat therapy (hyperthermia) can help treat viral warts in people who are pregnant, have HIV/AIDS, autoimmune diseases, diabetes, take immune-suppressing drugs, or are children. It aims to find a safe and effective option for these groups.

Shenyang, Liaoning
NCT07246590Recruiting· Phase 3
Cantharidin treatment for common warts in children and adults

This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.

Saint Augustine, Florida
NCT07637734Not yet recruiting· Phase 3
Testing cantharidin treatment for common warts

This study tests whether cantharidin—a liquid applied directly to common warts—can safely and effectively remove them. Common warts are bumpy growths caused by a virus that appear on hands, feet, and other body areas.

Overland Park, Kansas
NCT05625633Recruiting· Phase 2/Phase 3
HPV vaccine vs placebo for stubborn skin warts

This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.

Salt Lake City, Utah
NCT07457918Recruiting· Phase 3
Long-term safety of cantharidin gel for common warts

This study follows people who completed an earlier cantharidin trial to see how safe and effective the medicine is over a longer time. You may join if you still have treatable warts or finished the earlier study.

Saint Augustine, Florida

Hear when a new Warts trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.